Works matching AU Fazio, Sergio


Results: 75
    1
    2
    3
    4

    Plasma lipid levels and colorectal adenoma risk.

    Published in:
    Cancer Causes & Control, 2015, v. 26, n. 4, p. 635, doi. 10.1007/s10552-015-0555-y
    By:
    • Coppola, John-Anthony;
    • Shrubsole, Martha;
    • Cai, Qiuyin;
    • Smalley, Walter;
    • Dai, Qi;
    • Ness, Reid;
    • Fazio, Sergio;
    • Zheng, Wei;
    • Murff, Harvey
    Publication type:
    Article
    5

    Cover Image, Volume 22, Issue 3.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 5, p. 1, doi. 10.1111/dom.14053
    By:
    • Toth, Peter P.;
    • Fazio, Sergio;
    • Wong, Nathan D.;
    • Hull, Michael;
    • Nichols, Gregory A.
    Publication type:
    Article
    6

    Cover Image, Volume 22, Issue 3.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 1, doi. 10.1111/dom.13998
    By:
    • Toth, Peter P.;
    • Fazio, Sergio;
    • Wong, Nathan D.;
    • Hull, Michael;
    • Nichols, Gregory A.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Sex-Specific Parental Effects on Offspring Lipid Levels.

    Published in:
    2015
    By:
    • Predazzi, Irene M.;
    • Sobota, Rafal S.;
    • Sanna, Serena;
    • Bush, William S.;
    • Bartlett, Jacquelaine;
    • Lilley, Jessica S.;
    • Linton, MacRae F.;
    • Schlessinger, David;
    • Cucca, Francesco;
    • Fazio, Sergio;
    • Williams, Scott M.
    Publication type:
    journal article
    18
    19
    20

    Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial.

    Published in:
    European Heart Journal, 2023, v. 44, n. 16, p. 1408, doi. 10.1093/eurheartj/ehad144
    By:
    • Schwartz, Gregory G;
    • Szarek, Michael;
    • Bhatt, Deepak L;
    • Bittner, Vera A;
    • Bujas-Bobanovic, Maja;
    • Diaz, Rafael;
    • Fazio, Sergio;
    • Fras, Zlatko;
    • Goodman, Shaun G;
    • Harrington, Robert A;
    • Jukema, J Wouter;
    • Manvelian, Garen;
    • Pordy, Robert;
    • Ray, Kausik K;
    • Scemama, Michel;
    • White, Harvey D;
    • Steg, Ph Gabriel;
    • Investigators, for the ODYSSEY OUTCOMES
    Publication type:
    Article
    21

    Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.

    Published in:
    European Heart Journal, 2020, v. 41, n. 24, p. 2313, doi. 10.1093/eurheartj/ehz962
    By:
    • Borén, Jan;
    • Chapman, M John;
    • Krauss, Ronald M;
    • Packard, Chris J;
    • Bentzon, Jacob F;
    • Binder, Christoph J;
    • Daemen, Mat J;
    • Demer, Linda L;
    • Hegele, Robert A;
    • Nicholls, Stephen J;
    • Nordestgaard, Børge G;
    • Watts, Gerald F;
    • Bruckert, Eric;
    • Fazio, Sergio;
    • Ference, Brian A;
    • Graham, Ian;
    • Horton, Jay D;
    • Landmesser, Ulf;
    • Laufs, Ulrich;
    • Masana, Luis
    Publication type:
    Article
    22

    Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.

    Published in:
    European Heart Journal, 2017, v. 38, n. 32, p. 2459, doi. 10.1093/eurheartj/ehx144
    By:
    • Ference, Brian A.;
    • Ginsberg, Henry N.;
    • Graham, Ian;
    • Ray, Kausik K.;
    • Packard, Chris J.;
    • Bruckert, Eric;
    • Hegele, Robert A.;
    • Krauss, Ronald M.;
    • Raal, Frederick J.;
    • Schunkert, Heribert;
    • Watts, Gerald F.;
    • Borén, Jan;
    • Fazio, Sergio;
    • Horton, Jay D.;
    • Masana, Luis;
    • Nicholls, Stephen J.;
    • Nordestgaard, Børge G.;
    • Sluis, Bart van de;
    • Taskinen, Marja-Riitta;
    • Tokgözoğlu, Lale
    Publication type:
    Article
    23
    24
    25
    26
    27

    Plasma Lipidomic Patterns in Patients with Symptomatic Coronary Microvascular Dysfunction.

    Published in:
    Metabolites (2218-1989), 2021, v. 11, n. 10, p. 648, doi. 10.3390/metabo11100648
    By:
    • Lindner, Jonathan R.;
    • Davidson, Brian P.;
    • Song, Zifeng;
    • Maier, Claudia S.;
    • Minnier, Jessica;
    • Stevens, Jan Frederick;
    • Ferencik, Maros;
    • Taqui, Sahar;
    • Belcik, J. Todd;
    • Moccetti, Federico;
    • Layoun, Michael;
    • Spellman, Paul;
    • Turker, Mitchell S.;
    • Tavori, Hagai;
    • Fazio, Sergio;
    • Raber, Jacob;
    • Bobe, Gerd
    Publication type:
    Article
    28

    Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES.

    Published in:
    European Journal of Preventive Cardiology, 2024, v. 31, n. 10, p. e75, doi. 10.1093/eurjpc/zwae110
    By:
    • Szarek, Michael;
    • Reijnders, Esther;
    • Steg, Ph Gabriel;
    • Jukema, J Wouter;
    • Schwertfeger, Markus;
    • Bhatt, Deepak L;
    • Bittner, Vera A;
    • Diaz, Rafael;
    • Fazio, Sergio;
    • Garon, Genevieve;
    • Goodman, Shaun G;
    • Harrington, Robert A;
    • White, Harvey D;
    • Zeiher, Andreas M;
    • Cobbaert, Christa;
    • Schwartz, Gregory G
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Local effects of human PCSK9 on the atherosclerotic lesion.

    Published in:
    Journal of Pathology, 2016, v. 238, n. 1, p. 52, doi. 10.1002/path.4630
    By:
    • Giunzioni, Ilaria;
    • Tavori, Hagai;
    • Covarrubias, Roman;
    • Major, Amy S;
    • Ding, Lei;
    • Zhang, Youmin;
    • DeVay, Rachel M;
    • Hong, Liang;
    • Fan, Daping;
    • Predazzi, Irene M;
    • Rashid, Shirya;
    • Linton, MacRae F;
    • Fazio, Sergio
    Publication type:
    Article
    41
    42
    43
    44
    45

    Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial.

    Published in:
    Diabetes Care, 2025, v. 48, n. 4, p. 596, doi. 10.2337/dc24-2110
    By:
    • Schwartz, Gregory G.;
    • Szarek, Michael;
    • Jukema, J. Wouter;
    • Cobbaert, Christa M.;
    • Reijnders, Esther;
    • Bittner, Vera A.;
    • Schwertfeger, Markus;
    • Bhatt, Deepak L.;
    • Fazio, Sergio;
    • Garon, Genevieve;
    • Goodman, Shaun G.;
    • Harrington, Robert A.;
    • White, Harvey D.;
    • Steg, Philippe Gabriel
    Publication type:
    Article
    46
    47
    48
    49
    50

    Targeting PCSK9 for Therapeutic Gains.

    Published in:
    Current Atherosclerosis Reports, 2015, v. 17, n. 4, p. 1, doi. 10.1007/s11883-015-0499-4
    By:
    • Shapiro, Michael;
    • Fazio, Sergio;
    • Tavori, Hagai
    Publication type:
    Article